Kevin R. Sayer

Director, AKESIS PHARMACEUTICALS, INC.

Companies

  • DexcomChair Aug 15, 2018 to now1
  • DexcomChief executive officer Mar 10, 2015 to Mar 14, 20252
  • DexcomPresident Jun 3, 2011 to Mar 14, 20253
  • DexcomBoard member Nov 8, 2007 to Jul 11, 20184
  • DexcomChief operating officer Mar 13, 2013 to Dec 16, 20145

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

  • Dexcom DXCM302,214 shares6$26.0M at $86.09Aug 20, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

  • Aug 20, 2026Sold 97 shares at $91.41 of Dexcom6
  • Aug 20, 2026Sold 7,351 shares at $90.78 of Dexcom6
  • Aug 20, 2026Sold 19,308 shares at $89.71 of Dexcom6
  • Jul 20, 2026Sold 26,756 shares at $76.32 of Dexcom7
  • Jul 6, 2026Sold 26,756 shares at $72.00 of Dexcom8
  • May 21, 2026Sold 26,759 shares at $72.00 of Dexcom9
  • Mar 8, 2026Shares withheld for tax 32,498 shares at $68.10 of Dexcom10
  • Mar 8, 2026Granted 32,749 shares of Dexcom10
  • Jan 29, 2026Shares withheld for tax 34,257 shares at $73.36 of Dexcom11
  • Jan 29, 2026Granted 71,218 shares of Dexcom11
  • Mar 12, 2025Sold 32,498 shares at $70.38 of Dexcom12
  • Mar 8, 2025Granted 85,490 shares of Dexcom13
  • Jan 29, 2025Sold 33,359 shares at $86.91 of Dexcom14
  • Jan 28, 2025Granted 68,503 shares of Dexcom14
  • Apr 8, 2024Sold 22,361 shares at $138.71 of Dexcom15
  • Apr 8, 2024Sold 27,272 shares at $137.96 of Dexcom15
  • Mar 12, 2024Sold 2,939 shares at $134.07 of Dexcom16
  • Mar 12, 2024Sold 20,930 shares at $133.55 of Dexcom16
  • Mar 12, 2024Sold 14,993 shares at $132.43 of Dexcom16
  • Mar 12, 2024Sold 12,470 shares at $131.47 of Dexcom16
  • Mar 12, 2024Sold 29,675 shares at $134.41 of Dexcom16
  • Mar 8, 2024Granted 51,692 shares of Dexcom17
  • Jan 16, 2024Sold 37,325 shares at $123.63 of Dexcom18
  • Jan 12, 2024Granted 72,709 shares of Dexcom18
  • Apr 3, 2023Sold 3,599 shares at $115.70 of Dexcom19